Storia in 1 fonti

This oral drug might make blood cancer treatment safer

A London-based startup, Poolbeg Pharma, is set to trial POLB 001 at six NHS hospitals, aiming to prevent cytokine release syndrome (CRS) in cancer immunotherapy patients.

Raccontata da

newsbytesapp.com

Timeline cronologica

domenica 14 giugno 2026·newsbytesapp.com
This oral drug might make blood cancer treatment safer
A London-based startup, Poolbeg Pharma, is set to trial POLB 001 at six NHS hospitals, aiming to prevent cytokine release syndrome (CRS) in cancer immunotherapy patients.